相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases
Peng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Possible overlapping time frames of acquisition and consolidation phases in object memory processes: a pharmacological approach
Sven Akkerman et al.
LEARNING & MEMORY (2016)
PDE5 inhibition improves acquisition processes after learning via a central mechanism
S. Akkerman et al.
NEUROPHARMACOLOGY (2015)
Object memory enhancement by combining sub-efficacious doses of specific phosphodiesterase inhibitors
E. Bollen et al.
NEUROPHARMACOLOGY (2015)
Developing treatments for cognitive deficits in schizophrenia: The challenge of translation
J. W. Young et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse modet of cognitive impairment in schizophrenia
Stoyo Karamihalev et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
The Novel Object Recognition Test in Rodents in Relation to Cognitive Impairment in Schizophrenia
Lakshmi Rajagopal et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
PDE5 Inhibition Improves Object Memory in Standard Housed Rats but Not in Rats Housed in an Enriched Environment: Implications for Memory Models?
Sven Akkerman et al.
PLOS ONE (2014)
Animal models of working memory: A review of tasks that might be used in screening drug treatments for the memory impairments found in schizophrenia
Paul A. Dudchenko et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Schizophrenia Is a Cognitive Illness Time for a Change in Focus
Rene S. Kahn et al.
JAMA PSYCHIATRY (2013)
Object recognition testing: Rodent species, strains, housing conditions, and estrous cycle
Nick P. van Goethem et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Object recognition testing: Methodological considerations on exploration and discrimination measures
Sven Akkerman et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Object recognition testing: Statistical considerations
Sven Akkerman et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB
Eric R. Kandel
MOLECULAR BRAIN (2012)
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Sharron H. Francis et al.
PHYSIOLOGICAL REVIEWS (2011)
Quality of life and cognitive dysfunction in people with schizophrenia
Yoshinori Ueoka et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Conditioned Avoidance Response in the Development of New Antipsychotics
M-L. G. Wadenberg
CURRENT PHARMACEUTICAL DESIGN (2010)
Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
Viktor Lakics et al.
NEUROPHARMACOLOGY (2010)
Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients
Iacopo Cancelli et al.
NEUROLOGICAL SCIENCES (2009)
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia
Jared W. Young et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
Olga A. H. Reneerkens et al.
PSYCHOPHARMACOLOGY (2009)
Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D-1 and serotonin 5-HT1A receptors
Taku Nagai et al.
PSYCHOPHARMACOLOGY (2009)
Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats
Charlotte Wiker et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme
J. A. Siuciak et al.
NEUROPHARMACOLOGY (2007)
Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive α2 adrenoceptor blockade:: experimental evidence
Marie-Louise Wadenberg et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Time-dependent involvement of cAMP and cGMP in consolidation of object memory: Studies using selective phosphodiesterase type 2, 4 and 5 inhibitors
Kris Rutten et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Interleaving brain systems for episodic and recognition memory
John P. Aggleton et al.
TRENDS IN COGNITIVE SCIENCES (2006)
Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action
K Rutten et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2006)
Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
Andrew T. Bender et al.
PHARMACOLOGICAL REVIEWS (2006)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry
M Zhao et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Transient inactivation of perirhinal cortex disrupts encoding, retrieval, and consolidation of object recognition memory
BD Winters et al.
JOURNAL OF NEUROSCIENCE (2005)
Quantitative analysis of the farnesyl transferase inhibitor lonafarnib (Sarasar(TM), SCH66336) in human plasma using high-performance liquid chromatography coupled with tandem mass spectrometry
NMGM Appels et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance
FG Boess et al.
NEUROPHARMACOLOGY (2004)
Nicotine improves sustained attention in mice:: Evidence for involvement of the α7 nicotinic acetylcholine receptor
JW Young et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Molecular pharmacological dissection of short- and long-term memory
LA Izquierdo et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2002)
Reversal of antipsychotic-induced working memory deficits by short-term doper D1 receptor stimulation
SA Castner et al.
SCIENCE (2000)
分享论文
